Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was up 4.2% during trading on Monday . The stock traded as high as $1.28 and last traded at $1.23. Approximately 744,794 shares were traded during mid-day trading, an increase of 32% from the average daily volume of 562,561 shares. The stock had previously closed at $1.28.

Separately, Zacks Investment Research upgraded shares of Ekso Bionics Holdings from a “hold” rating to a “buy” rating and set a $2.00 price target on the stock in a research report on Wednesday, July 26th.

In related news, insider Russ Angold sold 28,254 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $1.53, for a total value of $43,228.62. Following the transaction, the insider now owns 250,678 shares in the company, valued at $383,537.34. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last quarter, insiders purchased 41,264 shares of company stock worth $48,255 and sold 259,352 shares worth $399,373. 7.10% of the stock is owned by company insiders.

A number of institutional investors have recently bought and sold shares of EKSO. Vanguard Group Inc. boosted its holdings in Ekso Bionics Holdings by 32.9% in the second quarter. Vanguard Group Inc. now owns 711,082 shares of the company’s stock valued at $1,650,000 after acquiring an additional 176,197 shares during the last quarter. National Planning Corp boosted its holdings in Ekso Bionics Holdings by 116.2% in the second quarter. National Planning Corp now owns 234,450 shares of the company’s stock valued at $537,000 after acquiring an additional 126,000 shares during the last quarter. Carl Domino Inc boosted its holdings in Ekso Bionics Holdings by 74.7% in the second quarter. Carl Domino Inc now owns 82,054 shares of the company’s stock valued at $190,000 after acquiring an additional 35,088 shares during the last quarter. Independence Advisors LLC bought a new position in Ekso Bionics Holdings in the second quarter valued at about $1,840,000. Finally, Intellectus Partners LLC boosted its holdings in Ekso Bionics Holdings by 5.3% in the second quarter. Intellectus Partners LLC now owns 105,294 shares of the company’s stock valued at $244,000 after acquiring an additional 5,294 shares during the last quarter. Institutional investors and hedge funds own 6.04% of the company’s stock.

WARNING: This report was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/09/25/ekso-bionics-holdings-inc-ekso-trading-up-4-2.html.

About Ekso Bionics Holdings

Ekso Bionics Holdings, Inc designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness.

Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.